BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a leading oncology firm, and NewBridge Pharmaceuticals have mutually decided to conclude their partnership in the MENA region. This strategic move is aligned…
RedSail Technologies, a top provider of pharmacy solutions, has received a strategic growth investment from Leonard Green & Partners (LGP). Additionally, Francisco Partners (FP), the company’s creator through the merging…
Agenus has announced groundbreaking results from a clinical trial, published in Nature Medicine, showcasing the potential of a novel immunotherapy combination for treating microsatellite stable metastatic colorectal cancer (MSS mCRC),…
Prepare for an electrifying experience as NRC Health unveils the keynote speaker for its highly anticipated 30th annual conference, Human Understanding Beyond | HUB24! Save the date for August 21–23,…
“Kiwi Olympic Hopeful David Liti Wows Residents with Weightlifting Demo” Residents at Logan Campbell Retirement Village were treated to an exciting weightlifting demonstration by David Liti, a newly-announced Olympic hopeful…
Following the announcement of the sale of Vamed’s rehabilitation business, the global healthcare group Fresenius has initiated a structured exit from its investment in Vamed. An Austrian consortium of construction…
Michael Sen, CEO of Fresenius, expressed satisfaction with the company’s performance, citing an impressive start to the year. Sen attributed this success to the company’s intensified focus on Fresenius Kabi…
Cardinal Health at-Home Solutions plays a crucial role in equipping patients and caregivers with essential tools for in-home care. This article is part of a series shedding light on the…
Today, Meridian, a prominent managed care organization in Michigan and a wholly-owned subsidiary of Centene Corporation, along with the Centene Foundation, the philanthropic arm of Centene Corporation, announced a generous…
Substance misuse continues to pose a significant challenge in the United States. Prevention, defined as any action aimed at averting substance misuse and lessening its adverse health and societal impacts,…
MindMed (NASDAQ: MNMD), a clinical-stage biopharmaceutical company focused on developing innovative treatments for brain health disorders, unveiled data from its Phase 2b study of MM120 (lysergide d-tartrate) for treating Generalized…
Today, Mars, Incorporated revealed it’s in exclusive talks with Cerba HealthCare, aiming to acquire Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE Based in Massy, France, Cerba Vet operates…